fluorodeoxyglucose f18 has been researched along with African Lymphoma in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 25 (64.10) | 24.3611 |
2020's | 6 (15.38) | 2.80 |
Authors | Studies |
---|---|
Aftandilian, C; Baggott, C; Davis, KL; Erickson, C; Lacayo, N; Mackall, CL; Nadel, HR; Oak, J; Ramakrishna, S; Schultz, L; Walkush, A | 1 |
Ito, J; Iwabuchi, Y; Nakazawa, A; Shima, H; Shimada, H; Takaki, T | 1 |
Wen, Z; Zhuang, H | 1 |
Liu, Y | 1 |
Allmer, C; Cerhan, JR; Habermann, TM; Harper, L; Higgins, A; Johnston, P; Kim, H; Maurer, MJ; Nowakowski, GS; Thanarajasingam, G; Thompson, CA; Witzig, TE; Young, JR | 1 |
Chen, Z; Huang, C; Miao, W; Xue, Q; Yao, S | 1 |
Fan, W; Li, R; Li, X; Long, W; Mo, Y; Wei, Y; Xiao, Z; Zhang, X | 1 |
Imai, Y; Ishikawa, T; Kazuma, Y; Matsuoka, R; Ochi, Y; Ono, Y | 1 |
Mokgoro, N; Reyneke, F; Sathekge, M; Vorster, M | 1 |
Dickson, JC; Haryee, H; Miller, RF; Vora, N | 1 |
McNeely, P; Menda, Y; Saad Aldin, E | 1 |
Colletti, PM; Maffione, AM; Pecori, S; Rampin, L; Rossella, P; Rubello, D | 1 |
Avigdor, A; Ben-Haim, S; Benjamini, O; Chikman, B; Davidson, T; Goshen, E; Nissan, E; Nissan, J; Priel, E; Raskin, S; Salomon, O; Schiby, G | 1 |
Albano, D; Bertagna, F; Bosio, G; Giubbini, R; Pagani, C; Re, A | 1 |
Albano, D; Bertagna, F; Bosio, G; Giubbini, R; Pagani, C; Re, A; Tucci, A | 1 |
Altini, C; Ingravallo, G; Niccoli Asabella, A; Pisani, AR; Rubini, G | 1 |
Halaç, M; Sager, S; Sen, F; Uslu, L | 1 |
Allen, CE; Bollard, CM; Dreyer, Z; Eissa, HM; Goradia, P; Guillerman, RP; Kamdar, K; McClain, KL; Simko, S; Steuber, P | 1 |
Borrego-Dorado, I; Capote, FJ; Carrillo-Cruz, E; de la Cruz Vicente, F; Espigado Tocino, I; Manzanares Pérez, M; Marín-Oyaga, VA; Pérez-Simón, JA; Pérez-Vega, H; Quiroga Cantero, E; Ramírez Sánchez, MJ; Solé Rodríguez, M; Vázquez-Albertino, R | 1 |
Harish, K; Maka, V | 1 |
Marangmei, C; Sharma, P | 1 |
Bortz, H; Corallo, CE; Coutsouvelis, J; Patil, S; Spencer, A | 1 |
Borrego Dorado, I; García Gómez, FJ; Jiménez Granero, P; Ruiz Mercado, M | 1 |
Lumachi, F; Rizzo, G; Sivolella, S; Valente, M | 1 |
Fan, W; Huang, JJ; Jiang, WQ; Li, WY; Li, ZM; Wei, WX; Xia, Y; Zhang, X | 1 |
Dirlik Serim, B; Durmus Altun, G; Gurleyen Eren, T; Oz Puyan, F | 1 |
Abdel Rahman, H; Hamoda, A; Hassanein, O; Moussa, E; Omar, W; Raafat, T; Sedky, M; Youssef, A | 1 |
Delbeke, D; McKay, JW; Sandler, MP | 1 |
Baillet, G; Fieschi, C; Galicier, L; Just, PA; Moretti, JL; Oksenhendler, E | 1 |
de Leval, L; Delrez, R; Depas, G; Dresse, MF; Etienne, I; Forget, P; Guidi, O; Hoyoux, C; Jacquemart, C | 1 |
Cho, SM; Galt, JR; Halkar, R; Lechowicz, MJ; Winton, E; Zeng, W | 1 |
Durski, JM; Georgiou, E; Johnston, PB; Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; Wiseman, GA | 1 |
Abdel-Dayem, HM; Hafez, M; Omar, W; Riad, R; Sidhom, I; Zaky, I; Zamzam, M | 1 |
Chen, Z; Tang, G; Wang, X; Zhang, X | 1 |
Balzarini, J; Bormans, G; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Vandenberghe, P; Verhoef, G | 1 |
Handa, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Tsukamoto, N; Uchiumi, H; Yokohama, A | 1 |
Chang, YL; Kao, CH; Pan, MH; Wu, YW; Yen, RF | 1 |
Bloom, DA; Chander, S; Joyrich, RN; Littrup, PJ; Webster, GC; Zak, IT; Zerin, JM; Zingas, AP | 1 |
Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 1 |
39 other study(ies) available for fluorodeoxyglucose f18 and African Lymphoma
Article | Year |
---|---|
Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD.
Topics: Bone Marrow; Burkitt Lymphoma; Child; Female; Fluorodeoxyglucose F18; Humans; Leukemia; Neoplasm, Residual; Positron-Emission Tomography; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
Refractory Burkitt Lymphoma With False-positive and False-negative Mass Detected on Positron Emission Tomography-computed Tomography After Chemotherapy.
Topics: Burkitt Lymphoma; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Burkitt's Lymphoma Involving Multiple Hormone-Producing Organs on FDG PET/CT.
Topics: Burkitt Lymphoma; Fluorodeoxyglucose F18; Hormones; Humans; Male; Positron Emission Tomography Computed Tomography; Young Adult | 2019 |
Giant primary breast Burkitt's lymphoma demonstrated on FDG PET/CT.
Topics: Breast Neoplasms; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Testicular FDG-PET/CT uptake threshold in aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testis; Young Adult | 2021 |
Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
Topics: Adolescent; Burkitt Lymphoma; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Leukemia; Male; Peptides, Cyclic; Positron Emission Tomography Computed Tomography | 2022 |
Value of baseline and end of chemotherapy
Topics: Burkitt Lymphoma; Child; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Two Cases of Neurolymphomatosis with Fatal Bilateral Vocal Cord Paralysis that were Diagnosed with
Topics: Adult; Animals; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Hoarseness; Humans; Laryngeal Nerves; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Vocal Cord Paralysis | 2017 |
Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report.
Topics: Adult; Breast; Burkitt Lymphoma; Cavernous Sinus; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syndrome; Vascular Neoplasms | 2017 |
Burkitt non-Hodgkin lymphoma presenting with mental neuropathy ('numb chin' syndrome) in an HIV-positive patient.
Topics: Adult; Burkitt Lymphoma; Chin; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography | 2018 |
Posterior Reversible Encephalopathy Syndrome on 18F-FDG PET/CT in a Pediatric Patient With Burkitt's Lymphoma.
Topics: Biological Transport; Burkitt Lymphoma; Child; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Posterior Leukoencephalopathy Syndrome | 2018 |
False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt Lymphoma.
Topics: Adult; Burkitt Lymphoma; False Positive Reactions; Filgrastim; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Liver; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2018 |
Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT.
Topics: Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Splenic Neoplasms | 2018 |
Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt's lymphoma: the role of Deauville and IHP criteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Burkitt Lymphoma; Disease Management; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2019 |
18F-FDG PET/CT metabolic activity assessment in infective and neoplastic diseases: a patient with systemic hydatidosis and concomitant Burkitt lymphoma.
Topics: Aged; Burkitt Lymphoma; Echinococcosis; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with 18F-FDG PET/CT.
Topics: Burkitt Lymphoma; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Peritoneal Diseases; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chemoradiotherapy; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2014 |
Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Multiple chest wall swellings in adult Burkitt's lymphoma.
Topics: Bone Neoplasms; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Sternum; Thoracic Wall; Tomography, X-Ray Computed | 2014 |
Tubercular Meningitis on 18F-FDG PET/CT: Incidentally Detected and Masquerading as Relapse in a Patient With Ovarian Burkitt Lymphoma.
Topics: Adolescent; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Meningeal | 2015 |
Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Motor Neuron Disease; Neurotoxicity Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction | 2015 |
18F-FDG PET/CT in Extranodal Burkitt Lymphoma.
Topics: Adult; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Sporadic Burkitt Lymphoma Mimicking Osteomyelitis of the Mandible Revealing Clinically Unsuspected HIV Infection.
Topics: Burkitt Lymphoma; Diagnosis, Differential; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Mandible; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2015 |
18F-FDG PET/CT Imaging of Burkitt Lymphoma Presenting With Unusual Muscle Involvement.
Topics: Burkitt Lymphoma; Child; Female; Fluorodeoxyglucose F18; Humans; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin's lymphoma. CCHE experience.
Topics: Adolescent; Burkitt Lymphoma; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Fluorodeoxyglucose F18; Hospitals, Pediatric; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Lymphoma and Lactic Acidosis.
Topics: Acidosis, Lactic; Adult; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; Male; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma.
Topics: Adult; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, AIDS-Related; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
Pediatric gastric lymphoma: a rare entity.
Topics: Adolescent; Burkitt Lymphoma; Fluorodeoxyglucose F18; Helicobacter Infections; Helicobacter pylori; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2008 |
Spectrum of FDG PET/CT findings in Burkitt lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
18F-FDG PET and PET/CT in Burkitt's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkitt Lymphoma; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2010 |
False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
Topics: Burkitt Lymphoma; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT.
Topics: Biopsy; Burkitt Lymphoma; Child; Fluorodeoxyglucose F18; Humans; Kidney; Male; Mesentery; Omentum; Peritoneum; Pleura; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Burkitt Lymphoma; Cell Division; Cyclophosphamide; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2003 |
Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; Fluorodeoxyglucose F18; Genes, myc; Humans; L-Lactate Dehydrogenase; Male; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, Emission-Computed | 2004 |
Gallium-67 scintigraphy and f-18 fluorodeoxyglucose position emission tomography in posttransplant lymphoproliferative disorder.
Topics: Adult; Burkitt Lymphoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Transplantation; Humans; Lymphoproliferative Disorders; Male; Postoperative Complications; Tomography, Emission-Computed | 2004 |
American Burkitt's lymphoma of the head and neck: evaluation with serial FDG-PET.
Topics: Adult; Antineoplastic Agents; Burkitt Lymphoma; Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2004 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |